ARCHIVES

Tamoxifen Trial may EB Funded In Part With CCOP Money

This article is from The Cancer Letter archive.

Vol. 17 No. 12 | March 22, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

November 18, 2011

In Brief: Peter Pisters named CEO of University Health Network in Toronto

August 8, 2014

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

American Cancer Society elected new officers.

December 3, 2004

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010